Clinical trial
Monoclonal Antibody Therapy in Treating Patients With Brain Metastases
NCT00002751 · Duke University, Other · Completed
Key facts
| NCT number | NCT00002751 |
|---|---|
| Title | Monoclonal Antibody Therapy in Treating Patients With Brain Metastases |
| Official title | PROTOCOL FOR A PHASE I STUDY OF INTRATHECAL MONOCLONAL ANTIBODY FRAGMENT 131I Me1-14 F(ab')2 IN PATIENTS WITH NEOPLASMS METASTATIC TO THE LEPTOMENINGES |
| Lead sponsor | Duke University, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Cancer |
| Intervention type | Biological |
| Interventions | monoclonal antibody Me1-14 F(ab')2 |
| Enrollment | 6 |
| Start date | Jul 1, 1989 |
| Completion | May 1, 2004 |
| First posted | Jul 1, 2004 |
| Last update posted | Jun 20, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: